Oral Rapamycin for Recalcitrant Restenosis - Oral Rapamycin for Recalcitrant Restenosis

Description:

The goal of the trial was to evaluate the safety and feasibility of the use of oral rapamycin after coronary angioplasty in patients at high risk for restenosis.